Opinion · 30 Dec 2024
Conference abstract
Overcoming challenges in pediatric clinical development
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Many of the drugs used in children have never been tested and licensed to use in pediatric population. Therefore, offlabel use in the pediatrics is widespread ~ 45% in various settings including lifesaving situations. Medicines tested and developed for adults may not have the same efficacy and safety profile in children, as the pediatric population is not same as adult. Children have different pharmacokinetic and pharmacodynamic profile than adults and they develop different type of adverse drug reactions to the same drugs. Therefore, they need different dosing, formulation and schedule to treat even similar diseases as in adults. Therefore, drugs in children should be thoroughly tested and tried in the appropriate population and indications to get the information on dosing schedule. Lack of appropriate labeling information and formulation may expose children to unwanted side effects and lack of efficacy. In recent years, there has been lot of regulatory and public interest of protecting children through research, leading to early evaluation of medicines in pediatric populations. Current ICH guidelines and FDA [BPCA, PREA, FDASIA and EMA (PIP)] regulations clearly mandate conducting clinical trials in children in order to get the marketing authorizations in adult indications and these regulations are binding to the MAHs. It has been a challenge to the MAHs to conduct clinical trials in children, as the strategies, designing and execution of clinical trials are not same as of the adult clinical trials. In this session, the practical challenges of the pediatric clinical trials will be discussed, along with strategies to overcome the hurdles in designing and execution of such trials. PDF HTML
Keywords
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 22 Aug 2016
Overcoming challenges in conducting clinical trials in Egypt- 10 years experience
Commentary · 30 Oct 2024
Formulation Development for Biopharmaceuticals: Overcoming Challenges in Delivery and Patient Compliance
Other · 13 Jul 2016
Clinical trials in pediatric multiple sclerosis: overcoming the challenges
Article · 31 Dec 2025
Ethical Challenges in Pediatric Clinical Research: Balancing Protection and Progress
More from this journal
The newest in Advances in Pharmacoepidemiology and Drug Safety.
Article · 10 Sep 2026
Periodic Safety Update Reports as an Essential Component of Continuous Drug Safety Monitoring
Article · 19 Dec 2025
Diabetes Medication Safety: Promoting Effective Glycemic Control Through Careful Therapeutic Management
Article · 19 Dec 2025
Drug Overdose Prevention: Strategies for Safe Medication Use and Public Health Protection
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalAdvances in Pharmacoepidemiology and Drug Safety
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Anup Choudhury”

